Axiom Investors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-4,821
Closed -$1.82M 136
2015
Q2
$1.82M Buy
4,821
+374
+8% +$142K 0.05% 109
2015
Q1
$1.86M Buy
4,447
+530
+14% +$222K 0.05% 118
2014
Q4
$1.07M Buy
3,917
+887
+29% +$243K 0.03% 141
2014
Q3
$589K Buy
+3,030
New +$589K 0.01% 149